{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:59:14Z","timestamp":1775714354032,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,14]],"date-time":"2027-03-14T00:00:00Z","timestamp":1804982400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS136524"],"award-info":[{"award-number":["R01NS136524"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151402","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:22:57Z","timestamp":1773249777000},"page":"151402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibition"],"prefix":"10.1016","volume":"354","author":[{"given":"Hossam","family":"Nada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson Garc\u00eda","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151402_bb0005","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151402_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","author":"A.s. Association","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151402_bb0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151402_bb0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12035-025-05354-x","article-title":"CHI3L1: an emerging player in neuroinflammation and neurodegeneration","volume":"63","author":"Mushtaq","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151402_bb0040","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151402_bb0045","first-page":"3599","article-title":"Astrocytes and microglia in the coordination of CNS development and homeostasis","volume":"168","author":"Lopez-Ortiz","year":"2024","journal-title":"J. Neurochem."},{"issue":"null","key":"10.1016\/j.ijbiomac.2026.151402_bb0050","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.2147\/JIR.S483412","article-title":"Prevention and treatment strategies for Alzheimer\u2019s disease: focusing on microglia and astrocytes in neuroinflammation","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151402_bb0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1871527319666200702143719","article-title":"Resolution-associated molecular patterns (RAMPs) as endogenous regulators of glia functions in neuroinflammatory disease","volume":"19","author":"Wenzel","year":"2020","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151402_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11882-018-0817-3","article-title":"Danger-associated molecular patterns (DAMPs): the derivatives and triggers of inflammation","volume":"18","author":"Patel","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0065","article-title":"Neuroinflammation induces neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0070","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/07853890.2021.1966088","article-title":"Role of neurotoxicants in the pathogenesis of Alzheimer\u2019s disease: a mechanistic insight","volume":"53","author":"Nisa","year":"2021","journal-title":"Ann. Med."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.151402_bb0075","doi-asserted-by":"crossref","first-page":"eadv1492","DOI":"10.1126\/sciadv.adv1492","article-title":"CHI3L1\/YKL-40 signaling inhibits neurogenesis in models of Alzheimer\u2019s disease","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/alz.12612","article-title":"Potential role of chitinase-3-like protein 1 (CHI3L1\/YKL-40) in neurodegeneration and Alzheimer\u2019s disease","volume":"19","author":"Connolly","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151402_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107365","article-title":"Evolutionary insights into sequence modifications governing chitin recognition and chitinase inactivity in YKL-40 (HC-gp39, CHI3L1)","volume":"300","author":"Suzuki","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151402_bb0090","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/pmic.201400421","article-title":"Structural and functional evolution of chitinase-like proteins from plants","volume":"15","author":"Kesari","year":"2015","journal-title":"PROTEOMICS"},{"key":"10.1016\/j.ijbiomac.2026.151402_bb0095","series-title":"Targeting Chitin-containing Organisms","first-page":"221","article-title":"Human chitinases: structure, function, and inhibitor discovery","author":"Kumar","year":"2019"},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.151402_bb0100","doi-asserted-by":"crossref","first-page":"37753","DOI":"10.1074\/jbc.M303137200","article-title":"Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39","volume":"278","author":"Fusetti","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151402_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/10408360802334743","article-title":"Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics","volume":"45","author":"Coffman","year":"2008","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151402_bb0115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4062\/biomolther.2025.050","article-title":"Chitinase-3-like protein 1 as a therapeutic target for inflammatory diseases","volume":"33","author":"Gu","year":"2025","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151402_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-025-00801-8","article-title":"Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications","volume":"20","author":"Mwale","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151402_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233519","article-title":"Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases","volume":"15","author":"Ku\u0161nierov\u00e1","year":"2020","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.151402_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells13242086","article-title":"CHI3L1 in multiple sclerosis-from bench to clinic","volume":"13","author":"Jatczak-Pawlik","year":"2024","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151402_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70619","article-title":"Chitinase-3-like 1 protein (CHI3L1) levels in patients with cognitive deficits and movement disorders: comparison with other biomarkers","volume":"15","author":"Novobilsk\u00fd","year":"2025","journal-title":"Brain Behav."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151402_bb0140","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00415-011-6087-9","article-title":"Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer\u2019s disease","volume":"258","author":"Choi","year":"2011","journal-title":"J. Neurol."},{"issue":"39","key":"10.1016\/j.ijbiomac.2026.151402_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg8148","article-title":"CHI3L1 signaling impairs hippocampal neurogenesis and cognitive function in autoimmune-mediated neuroinflammation","volume":"9","author":"Jiang","year":"2023","journal-title":"Sci. Adv."},{"issue":"574","key":"10.1016\/j.ijbiomac.2026.151402_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax3519","article-title":"Chi3l1\/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer\u2019s disease pathogenesis","volume":"12","author":"Lananna","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.151402_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117960","article-title":"CHI3L1-targeted small molecules as glioblastoma therapies: virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroids","volume":"297","author":"Nada","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151402_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cmdc.201300447","article-title":"Discovery of 5\u2033-Chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2\u2032:5\u2032,3\u2033-terpyridine-3\u2032-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia","volume":"9","author":"Roecker","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2026.151402_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117924","article-title":"Lead optimization of a CHI3L1 inhibitor for glioblastoma: enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid models","volume":"297","author":"Kaur","year":"2025","journal-title":"Eur. J. Med. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:32:19Z","timestamp":1775712739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026013280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"alternative-id":["S0141813026013280"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151402","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibition","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151402"}}